Oncolytic virotherapy provides a potent therapy option for squamous bladder cancer

Oncolytic virotherapy provides a potent therapy option for squamous bladder cancer

Abstract Prognosis for squamous cell carcinoma (SCC) of the bladder is limited mostly because of lack of effective treatment regimens. Oncolytic virotherapy represents a promising option for bladder cancer and received in 2024 FDA therapy designation for the treatment of non-invasive high-grade blad...

Full description

Saved in:
Bibliographic Details
Main Authors: Julia Pannhausen, Julia Wirtz, Klaus Mantwill, Per-Sonne Holm, Kristina Schwamborn, Danny D. Jonigk, Jürgen E. Gschwend, Michael Rose, Nadine T. Gaisa, Roman Nawroth
Format: Article
Language:English
Published: Nature Portfolio 2025-04-01
Series:Scientific Reports
Subjects:
Bladder cancer
Oncolytic virus
Squamous cell carcinoma
Virotherapy
XVir-N-31
YB-1
Online Access:https://doi.org/10.1038/s41598-025-96419-3
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-96419-3

Similar Items